Advertisement

Advertisement

COVID-19

What Is ‘Quality Oncology Care’ During the COVID-19 Pandemic?

My patient with metastatic colon cancer was sitting across from me after being absent for several months. His cancer had been under excellent control on chemotherapy, but now he was having worse pain and shortness of breath. Despite our calls, he had not kept his appointments. We were 6 feet apart, ...

COVID-19

Impact of COVID-19 on Cancer Care in India

With the announcement of a complete nationwide lockdown on March 25, 2020, to prevent the spread of COVID-19, a lot of unprecedented events came into being in India. The National Health Mission reported a 69% reduction in measles, mumps, and rubella vaccination in children; a 21% reduction in...

COVID-19

FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

The U.S. Food and Drug Administration (FDA) has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) for December 10, 2020, to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, in partnership with BioNTech. “The...

COVID-19

Emergency Use Authorization Request to Be Submitted to FDA Today for COVID-19 Vaccine

Pfizer Inc and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the United...

covid-19

Dafna Bar-Sagi, PhD, on COVID-19: How Cancer Researchers Can Help Address the Challenges

Dafna Bar-Sagi, PhD, of New York University Langone Medical Center, summarizes a panel discussion she moderated on skills the cancer research community brings to bear on the coronavirus pandemic, how the influx of funding will affect future priorities, and ways to capitalize on the surge of interdisciplinary efforts to address medical issues. The panel was composed of: Ann D. Barker, Chief Strategy Officer at the Ellison Institute of University of Southern California.  Previously, Ann served as the Principal Deputy Director of the National Cancer Institute for strategic scientific initiatives.   Tyler Jacks, Director of Koch Institute for Integrative Cancer Research at MIT. Tom Lynch, President and Director of Fred Hutchinson Cancer Research Center. Shiva Malek, Senior Director and Principal Scientist of Discovery Oncology at Genentech. J.T. Poirier, a junior faculty from the Perlmutter Cancer Center at NYU Langone Health.

COVID-19

FDA Issues Emergency Use Authorization for First COVID-19 Test for Self-Testing at Home

On November 17, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home. The Lucira COVID-19 All-In-One Test Kit, which provides rapid results, is a molecular (real-time loop mediated amplification...

Supportive Care
Integrative Oncology
COVID-19

Virtual Mind-Body Services for Patients With Cancer During the COVID-19 Pandemic

The ASCO Post’s Integrative Oncology series is intended to facilitate the availability of evidence-based information on integrative and complementary therapies sometimes used by patients with cancer. In this installment, Jun J. Mao, MD, MSCE, and Jyothirmai Gubili, MS, focus on the role of virtual...

COVID-19

Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

A portion of patients with cancer may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic. According to a report published as a research letter by Mark E. Fleury, PhD, and colleagues in JAMA Oncology, nearly one in five patients with cancer surveyed said the...

COVID-19

Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

In a United Arab Emirates single-institution study reported as a research letter in JAMA Oncology, Al-Shamsi et al found a high rate of COVID-19 infection among asymptomatic patients with solid tumors undergoing cancer treatment. Study Details The study included 109 patients receiving treatment for ...

COVID-19

COVID-19’s Impact on Cancer Care Around the World: Perspectives From the ASCO International Affairs Committee

As the world continues to respond to the COVID-19 pandemic, ASCO is committed to providing the most current information and resources to its members and the larger oncology community to help ensure that patients with cancer receive high-quality care. Here, members of the ASCO International Affairs...

Issues in Oncology
COVID-19

Results From ASCO’s 2020 National Cancer Opinions Survey

As in past years, the results from ASCO’s 2020 National Cancer Opinions Survey showed a startling dichotomy in the perceptions of Americans on a variety of health-care issues. As expected, the two major events this year, the COVID-19 pandemic and a national reckoning over racial injustice,...

COVID-19

Impact of COVID-19 on Well-Being in the Oncology Workforce: COVID-NOW Survey Results

The results of a survey of 1,038 doctors, nurses, pharmacists, administrators, and allied health professionals (such dietitians and physiotherapists) working in oncology in the United Kingdom’s National Health Service (NHS) during the spring wave of COVID-19 were presented by Susana N. Banerjee,...

COVID-19

UK-Based Study Finds Evidence of COVID-19 Infection, Antibody Presence in Oncology Health-Care Staff

A study of oncology staff carried out immediately after the spring peak of the COVID-19 pandemic in the United Kingdom indicated that many had been infected with the coronavirus, including those who did not show any symptoms. The study—presented by Favara et al at the NCRI (National Cancer Research ...

COVID-19

Survey Shows Many Patients With Cancer Willing to Take Part in Clinical Trials Despite Coronavirus

Patient Power, a patient-driven cancer news organization, reported that a majority of patients with cancer still want to participate in clinical trials despite the COVID-19 pandemic, according to a recent survey of 1,485 patients. The Patient Power COVID-19 Cancer Trial Survey, the second Patient...

COVID-19

Did You Know ASCO Has Resources on COVID-19 for People With Cancer?

ASCO’s award-winning Cancer.Net blog has been providing updated content and resources on COVID-19 for people with cancer since the pandemic started. Send your patients to www.cancer.net/blog for trusted COVID-19 information, financial resources, and more. All content is available in multiple...

Issues in Oncology
COVID-19

How Telemedicine Is Impacting Oncology Care During the COVID-19 Pandemic

The expansion of telemedicine has been one of the most important developments during the COVID-19 pandemic. Here, we discuss some of the legal and ethical dimensions of expanding telemedicine services in oncology practices. As Royce et al discussed in a recent JAMA Oncology article, Congress...

COVID-19

COVID-19, Cancer, and the Older Adult

An inspiring case series of fit patients aged 98 and older who recovered from hospitalization for COVID-19, published by Huang et al, reminds us that older age may not be a barrier to recovery.1 On behalf of the Cancer and Aging Research Group, we do not support “ageism” in the care of older...

COVID-19

FDA Approves Remdesivir for Patients With COVID-19 Requiring Hospitalization

On October 22, the U.S. Food and Drug Administration (FDA) approved the antiviral drug remdesivir (Veklury) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kg for the treatment of COVID-19 requiring hospitalization. Remdesivir should only be administered...

issues in oncology
covid-19

Cardinale B. Smith, MD, PhD, on Telehealth Disparities During the COVID-19 Pandemic

Cardinale B. Smith, MD, PhD, of the Icahn School of Medicine at Mount Sinai, discusses findings showing Black, Hispanic, and Asian patients with cancer used telehealth less often during the COVID-19 pandemic than White patients with cancer, a negative trend that will become more problematic as this method of care continues to increase through subsequent waves of coronavirus infection and plays a larger role in standard treatment (Abstract 87).

Issues in Oncology
COVID-19

Advanced Practitioner Leadership in Times of Crisis

In 2020, health-care providers from all disciplines are facing challenges never before encountered in the modern era of medicine. Advanced practitioners (APs) are playing critical roles in developing protocols, managing health-care teams, and delivering hands-on patient care. JADPRO Live, the...

breast cancer
covid-19

Melissa K. Accordino, MD, on Breast Cancer Care Delivery: Impact of the COVID-19 Pandemic

Melissa K. Accordino, MD, of Columbia University Medical Center, discusses findings showing nearly half of the patients with breast cancer treated at an academic center in New York City experienced a change or delay in their workup or treatment during the COVID-19 pandemic. Race and socioeconomic factors played a significant role (Abstract 88).

COVID-19

New Study Offers a Global Review of the Impact of COVID-19 on Cancer Treatment and Research

A recent review of scientific literature showed that the COVID-19 pandemic has impacted virtually every aspect of cancer care and research—from introducing new risks for patients to disrupting the delivery of treatment and the continuity of research. The report, published by Ziad Bakouny, MD, and...

COVID-19

Pulmonary Complication Rates After Elective Cancer Surgery in Hospitals With vs Without COVID-19–Free Surgical Pathways

In an international cohort study reported in the Journal of Clinical Oncology, Glasbey et al found that pulmonary complication rates after elective cancer surgery were lower in hospitals with vs without COVID-19–free surgical pathways during the COVID-19 pandemic. As stated by the investigators,...

COVID-19

Impact of Cytotoxic Chemotherapy Within 5 Weeks of COVID-19 Diagnosis in Patients With Cancer

In a single-institution study reported in the Journal of Clinical Oncology, Justin Jee, MD, PhD, of the Department of Medicine, Memorial Sloan Kettering Cancer Center (MSK), New York, and colleagues found that receipt of cytotoxic chemotherapy within 35 days of COVID-19 diagnosis in patients with...

Issues in Oncology
Gynecologic Cancers
Colorectal Cancer
COVID-19

A Primary Care Physician Explores Barriers to Cancer Prevention and Clinical Trial Accrual

To accelerate progress in the survival rates of people with cancer in the United States and to reduce cancer disparities across the entire spectrum of cancer from diagnosis to survivorship, there needs to be increased access to cancer screening and prevention programs. To shed light on this...

COVID-19
Issues in Oncology

Mobilizing for Greater Equity in Health Care Despite the Challenges of COVID-19

The lockdown phase of the coronavirus (COVID-19) pandemic and continued measures, such as social distancing, while necessary, are disrupting cancer care in ways that will have consequences for months, if not years, to come. Studies are showing that delayed or suspended cancer treatments,...

COVID-19

A Young Oncologist Cares for Patients With Cancer Amid COVID-19 Pandemic

The COVID-19 pandemic changed the face of U.S. health-care services in such rapid fashion that many providers were caught off guard, learning and preparing on the fly. Patients with cancer, given their multiple physical and emotional challenges, were especially vulnerable. To get a sense of the...

COVID-19

Cancer Centers Nationwide Join to Address the Impact of COVID-19 on Cancer Prevention and Treatment

A consortium of 17 cancer centers in the United States, including the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB), have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care, and prevention. The cancer ...

Issues in Oncology
COVID-19

CancerLinQ Data Reveal Black and Hispanic Patients With Cancer Face Greater Risk of COVID-19 Infection

Black and Hispanic patients with cancer were more likely to be infected with COVID-19 than White patients, based on the findings of a study of more than 477,000 patients to be presented by Potter et al at the upcoming virtual 2020 ASCO Quality Care Symposium (Abstract 84). About the Study...

Issues in Oncology
COVID-19

Black Patients With Cancer May Be at Increased Risk for Hospitalization Related to COVID-19 Infection

A study of more than 500 patients with cancer infected with COVID-19 at a large cancer center in Boston found that Black patients with cancer and COVID-19 were twice as likely to be hospitalized due to complications related to the virus as compared to White patients. Black patients were also more...

Issues in Oncology
COVID-19

Study Finds Black and Hispanic Patients With Cancer Used Telehealth Less Often Than White Patients During the COVID-19 Pandemic

During the peak of the COVID-19 pandemic, fewer Black and Hispanic patients with cancer used telehealth (including phone encounters and video visits) compared to White patients, according to findings from an analysis of data from New York City hospitals. Significant disparities in the use of...

Issues in Oncology
COVID-19

ASCO’s National Cancer Opinion Survey Reveals Concerns Over Delays in Cancer Screenings Due to COVID-19 and Inequities in Health Care

Findings from ASCO’s fourth annual National Cancer Opinion Survey showed the toll the COVID-19 pandemic is taking on patients with cancer and the concerns over delays in scheduling cancer screenings. In addition, a majority of survey respondents acknowledged that racism can impact the care a person ...

COVID-19

Leukemia & Lymphoma Society Launches First Clinical Trial in Patients With Hematologic Malignancy and COVID-19

In response to studies showing that between 30% and 60% of patients with blood cancer are at risk of death if infected with COVID-19 compared with patients who are cancer-free, the Leukemia & Lymphoma Society (LLS) has announced its launch of the first clinical trial dedicated solely to this...

COVID-19

COVID-19 Pandemic Delays Cancer Care and Strains Resources

Delays and cancellation of cancer treatments and other safety measures undertaken to minimize the risk of exposure to COVID-19 have generated a huge backlog in oncology care and research. The threat of delayed diagnoses looms while oncology professionals face burnout, according to new studies...

COVID-19

City of Hope Leads Novel Clinical Trial to Treat Patients With Cancer and COVID-19

City of Hope is investigating an innovative treatment for patients with cancer and COVID-19 by repurposing leflunomide, an anti-inflammatory drug for rheumatoid arthritis that is inexpensive and has few serious side effects, in a new clinical trial. Patients treated for cancer in the past 2 years...

COVID-19

Corticosteroids Improve Survival in Critically Ill Patients With COVID-19, According to International Trial

In a demonstration of global collaboration, clinician-scientists have pooled data from 121 hospitals in 8 countries to find that inexpensive, widely available steroids may improve the odds that very sick patients with COVID-19 will survive the illness. The findings were made through the Randomized...

Issues in Oncology
Legislation
Health-Care Policy
COVID-19

AACR Releases 10th Edition of Annual Cancer Progress Report

The American Association for Cancer Research (AACR) has released the 10th edition of its annual Cancer Progress Report. The report highlights how cancer research, largely supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI), is...

COVID-19

Joint Statement From the AMA, AHA, and ANA on U.S. Coronavirus Death Toll

Today, the American Medical Association (AMA), American Hospital Association (AHA), and American Nurses Association (ANA) released a joint statement on the amount of deaths caused by the coronavirus in the United States. Today we mark a somber milestone as more than 200,000 people in the United...

COVID-19

Cancer Treatment–Related Outcomes in Patients With Cancer and COVID-19

Researchers have found that certain treatments for cancer may increase the chance of death if they contract COVID-19. These findings from a multicenter study presented by Trisha Wise-Draper, MD, and colleagues at the ESMO Virtual Congress 2020 (LBA71), shed light on ways standard anticancer...

COVID-19

Effects of the COVID-19 Pandemic on Cancer Care, Provider Well-Being

Delays and cancellation of cancer treatments and other safety measures undertaken to minimize the risk of exposure to the coronavirus have generated a backlog in oncology care and research. The threat of delayed diagnoses looms while oncology professionals face burnout, according to new studies...

COVID-19

Viral Load May Help Predict Mortality Rate in Hospitalized Patients With Cancer and COVID-19

Higher viral loads may be associated with a greater risk of death among patients with cancer—and individuals without cancer—hospitalized with COVID-19, according to a report by Westblade et al in Cancer Cell. Among hospitalized patients infected with COVID-19, those with hematologic malignancies...

Issues in Oncology
Hematologic Malignancies
COVID-19

Cryopreservation May Be Associated With Loss of Quality in Donor Stem Cell Products

During the COVID-19 pandemic, many stem cell transplant centers (including guidance from the National Marrow Donor Program [NMDP]) recommend that stem cell products be frozen for preservation. However, findings from a study by Duncan Purtill, MD, and colleagues in Blood Advances suggest that the...

COVID-19

A Moment to Pause, Reflect, and Act Amid a Pandemic

In this period of time, more than ever before, I feel the dichotomy of being a non-Hispanic White American vs a person of color. Through the COVID-19 pandemic, I rode the subway to the Memorial Sloan Kettering Ralph Lauren Cancer Center clinic in Harlem, where I was often the only White person on...

COVID-19

CDC Data Show Disproportionate COVID-19 Impact in American Indian and Alaska Native Populations

The Centers for Disease Control and Prevention (CDC) released a new study that specifically examines how COVID-19 is affecting American Indians and Alaska Natives (AI/AN), one of the racial and ethnic minority groups at highest risk from the disease. The CDC found that in 23 selected states, the...

COVID-19

Mobilizing to Meet Challenges and Improve Survival for COVID-19–Positive Patients and Health-Care Professionals

Recognizing the COVID-19 crisis “as an opportunity to mobilize the organization to rise in the most difficult challenges” allowed The University of Texas MD Anderson Cancer Center, Houston, to keep mortality rates low for COVID-19–positive patients with cancer and its employees. So said Peter WT...

COVID-19

Chasing Cancer: Challenges to Providing Appropriate Care in the Age of COVID-19

The global impact of the novel coronavirus cannot be overstated, but its effects on cancer care delivery in the United States have been particularly far-reaching. The COVID-19 pandemic has resulted in fewer cancer screenings and reduction in the treatment of new cancers. As a result, the National...

COVID-19

How Delays in Screening and Early Cancer Diagnosis Amid the COVID-19 Pandemic May Result in Increased Cancer Mortality

Earlier this year, as the COVID-19 pandemic was spreading across the United States, federal health officials and cancer societies urged Americans to delay routine cancer screenings and other elective procedures to keep them out of clinics to avoid potential exposure to the coronavirus and to...

COVID-19
Hematologic Malignancies

COVID-19 Prevalence and Mortality in Patients With Cancer in the UK

In a UK study reported in The Lancet Oncology, Lee et al in the UK Coronavirus Cancer Monitoring Project (UKCCMP) found an increased prevalence of COVID-19 infection among patients with hematologic malignancies and increased risk of death from COVID-19 in patients with leukemia and those with...

Gynecologic Cancers
COVID-19

Gynecologic Oncologist Describes Practice in the Era of COVID-19

The ASCO Post spoke with Alexander Melamed, MD, MPH, a gynecologic oncologist and Assistant Professor of Obstetrics & Gynecology at NewYork-Presbyterian/Columbia University Medical Center, New York, at the onset of the COVID-19 pandemic in New York. New York state has had more coronavirus cases ...

Hematologic Malignancies
COVID-19

Are Patients With Hematologic Cancers More Vulnerable to the Effects of COVID-19?

A new study from the UK Coronavirus Cancer Monitoring Project (UKCCMP) has found that, compared with patients who have other malignancies, patients with blood cancers are more vulnerable to the effects of COVID-19 infection. These results were published by Lee et al in The Lancet Oncology. As...

Advertisement

Advertisement

Advertisement